(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMBINAÇÕES DE LURBINECTEDINA E ATEZOLIZUMABE

Em AnáliseInvention PatentPCT · EP2022081155
Talk to an expert

Application data

Invention Patent COMBINAÇÕES DE LURBINECTEDINA E ATEZOLIZUMABE de PHARMA MAR, S.A. — IPC A61K 31/4995
Invention Patent COMBINAÇÕES DE LURBINECTEDINA E ATEZOLIZUMABE de PHARMA MAR, S.A. — IPC A61K 31/4995. Drawing published by the INPI in the Industrial Property Gazette.

Number

112024009007

Type

Invention Patent

Filing

11/08/2022

Publication

08/13/2024

PCT

EP2022081155
View on INPI

Progress at the INPI

  1. Filing11/08/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 11/08/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/13/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PHARMA MAR, S.A.

ES

See this company's full portfolio

Inventors

L. R. (pessoa física)

ES

S. M. (pessoa física)

ES

S. A. (pessoa física)

ES

Technical data

IPC Classification

A61K 31/4995A61K 39/395A61P 35/00C07K 16/28

Priority claims

EP

21383013.6 · 11/08/2021

Abstract

COMBINAÇÕES DE LURBINECTEDINA E ATEZOLIZUMABE.A presente invenção refere-se a terapias de combinação para o tratamento de câncer pulmonar de células pequenas compreendendo lurbinectedina e atezolizumabe.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

08/13/2024

RPI 2797

Alteração de dados cadastrais

#1.1

05/14/2024

RPI 2784

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.